Meduloc, Inc. — SEC Form D Filing
Meduloc, Inc. filed an SEC Form D on August 6, 2026, reporting $1.84M raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- August 6, 2026
- Amount reported
- $1.84M
- Round stage
- Seed
- Industry
- Medical Devices
- Website
- https://www.meduloc.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
There is a need for improved fixation of small, long-bone fractures, implying current methods may not provide stable fixation or secure reduction.
Solution
Meduloc is developing minimally invasive, intramedullary implants designed to provide stable fixation and secure reduction for various small, long-bone fractures.
Why now
The demand for improved fixation methods in orthopedic surgery, particularly for small long bones, is an ongoing clinical need that Meduloc aims to address with innovative internal fixation solutions.
Verdict
This cleared because it promised a surgical efficacy upgrade in a specific, high-volume procedure, not because it disrupted a broad market. Investors were implicitly betting on a faster, more stable fixation method translating directly to better patient outcomes and surgeon preference, despite the sales cycle challenges of medical devices. The upside was limited by the relatively narrow application of small long-bone fractures, suggesting a potential feature, not a platform, unless further expansion was viable.
Source: SEC EDGAR Form D filing